CVE-2020-36609

Public Exploit
annyshow DuxCMS Article edit cross site scripting

Description

A vulnerability was found in annyshow DuxCMS 2.1. It has been classified as problematic. This affects an unknown part of the file admin.php&r=article/AdminContent/edit of the component Article Handler. The manipulation of the argument content leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-215115.

Category

2.4
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.03%
Third-Party Advisory gitee.com Third-Party Advisory vuldb.com
Affected: annyshow DuxCMS
Published at:
Updated at:

References

Link Tags
https://gitee.com/annyshow/DuxCMS2.1/issues/I183GG issue tracking exploit third party advisory
https://vuldb.com/?id.215115 third party advisory

Frequently Asked Questions

What is the severity of CVE-2020-36609?
CVE-2020-36609 has been scored as a low severity vulnerability.
How to fix CVE-2020-36609?
To fix CVE-2020-36609, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-36609 being actively exploited in the wild?
It is possible that CVE-2020-36609 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-36609?
CVE-2020-36609 affects annyshow DuxCMS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.